title: [Clinical efficacy of cefmetazole in intraabdominal infection].
abstract: A number of different organisms can be isolated from intraabdominal infection. The most common are aerobic Gram-negative bacilli. Anaerobes are not unusual. From June 1989 to January 1990, Cefmetazole was administered to 23 patients with intraabdominal infection at Veterans General Hospital-Taipei. There were six patients with spontaneous bacterial peritonitis, five biliary tract infection, five liver abscesses, five with pelvic inflammatory disease, one acute ruptured appendicitis and another intraabdominal abscess. In addition, ten patients had sepsis. Clinical response was satisfactory in 21 (91.3%) of 23 patients, and the microbiological eradication rate was 90% (36/40). One patient with Streptococcus and Bacteroides oralis liver abscess relapsed after organism eradication. Therapy failed in a case with Pseudomonas aeruginosa and Bacteroides fragilis infection. This study showed Cefmetazole to be an effective and safe antibiotic for treatment of intraabdominal infection.
authors.affiliation: Department of Medicine, Veterans General Hospital, Taichung.
authors.forename: B S
authors.initials: BS
authors.lastname: Hu
authors.forename: C Y
authors.initials: CY
authors.lastname: Liu
authors.forename: F D
authors.initials: FD
authors.lastname: Wang
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016470:Bacteremia / Q000188:drug therapy; D001424:Bacterial Infections / Q000188:drug therapy*; D001660:Biliary Tract Diseases / Q000188:drug therapy*; D015311:Cefmetazole / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008100:Liver Abscess / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy*; D010538:Peritonitis / Q000188:drug therapy*
chemical_list: D015311:Cefmetazole